June 30, 2022 The WTO DEAL explainer Educational Material, Vaccine Equity, Access and Allocation HJI explainer on the WTO DEAL explainer.
Educational Material, Fair Access, Gilead License FAQ: Gilead’s LENACAPAVIR (LEN-LA) license and implications for access
Litigation, Transparency, Vaccine Equity, Access and Allocation The HJI launches litigation for disclosure of South Africa’s Covid-19 vaccine contracts
